Lipocine Inc.
LPCN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $115 | $623 | $94 | $3,491 |
| % Growth | -81.6% | 563.6% | -97.3% | – |
| Cost of Goods Sold | $0 | $2,137 | $0 | $0 |
| Gross Profit | $115 | -$1,514 | $94 | $3,491 |
| % Margin | 100% | -243.1% | 100% | 100% |
| R&D Expenses | $2,708 | $2,121 | $1,062 | $1,073 |
| G&A Expenses | $768 | $890 | $1,122 | $873 |
| SG&A Expenses | $768 | $890 | $1,122 | $873 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$2,121 | $0 | $0 |
| Operating Expenses | $3,476 | $890 | $2,184 | $1,946 |
| Operating Income | -$3,361 | -$2,404 | -$2,090 | $1,545 |
| % Margin | -2,933.5% | -386% | -2,226.8% | 44.3% |
| Other Income/Exp. Net | $174 | $199 | $226 | $237 |
| Pre-Tax Income | -$3,187 | -$2,206 | -$1,865 | $1,782 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3,187 | -$2,206 | -$1,865 | $1,782 |
| % Margin | -2,781.5% | -354.1% | -1,986.8% | 51% |
| EPS | -0.59 | -0.41 | -0.35 | 0.33 |
| % Growth | -43.9% | -17.1% | -206.1% | – |
| EPS Diluted | -0.59 | -0.41 | -0.35 | 0.32 |
| Weighted Avg Shares Out | 5,413 | 5,352 | 5,349 | 5,339 |
| Weighted Avg Shares Out Dil | 5,413 | 5,352 | 5,349 | 5,423 |
| Supplemental Information | – | – | – | – |
| Interest Income | $174 | $199 | $226 | $233 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $16 | $16 | $16 | $16 |
| EBITDA | -$3,345 | -$2,388 | -$2,075 | $1,561 |
| % Margin | -2,919.5% | -383.4% | -2,210.2% | 44.7% |